[Federal Register Volume 86, Number 174 (Monday, September 13, 2021)]
[Notices]
[Page 50903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19679]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-899]


Bulk Manufacturer of Controlled Substances Application: Eli-
Elsohly Laboratories

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Eli-Elsohly Laboratories has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before November 12, 
2021. Such persons may also file a written request for a hearing on the 
application on or before November 12, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 5, 2021, Eli-Elsohly Laboratories, 5 
Industrial Park Drive, Oxford, Mississippi 38655, applied to be 
registered as an bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
         Controlled substances             code          Schedule
------------------------------------------------------------------------
Marihuana Extract......................     7350  I
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
Amphetamine............................     1100  II
Methamphetamine........................     1105  II
Cocaine................................     9041  II
Codeine................................     9050  II
Dihydrocodeine.........................     9120  II
Ecgonine...............................     9180  II
Thebaine...............................     9333  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for product development and reference standards. In reference to drug 
codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company 
plans to isolate these controlled substances from procured 7350 
(Marihuana Extract). In reference to drug code 7360, no cultivation 
activities are authorized for this registration. In reference to drug 
code 9333 (Thebaine), the company plans to manufacture a Thebaine 
derivative. No other activities for these drug codes are authorized for 
this registration.

Brian S. Bresser,
Acting Assistant Administrator.
[FR Doc. 2021-19679 Filed 9-10-21; 8:45 am]
BILLING CODE P